Tesla shares extended their recovery Monday, climbing 1% to $332 in pre-market trading, as retail investors poured a net $372 million into the stock over the five trading days through Wednesday, according to JPMorgan data. This acceleration followed $121 million recorded the prior week, with nearly $800 million directed toward the stock over the past three weeks. The catalyst is Terafab, a $16.8 billion semiconductor and AI compute manufacturing complex planned for Grimes County, Texas, jointly backed by Tesla and SpaceX. The facility will produce custom chips for Tesla's Optimus humanoid robots and autonomous Cybercabs, with about 25% of its computational resources earmarked for Tesla initiatives and roughly 3,000 jobs anticipated. SpaceX also disclosed approximately $295 million in Tesla Megapack purchases during the second quarter. Tesla's stock has gained roughly 5% over the past five trading sessions, though it remains down 27% for the year, trading below its 50-day moving average of $378.76 and 200-day moving average of $393.46. Second-quarter results, reported on July 22, showed revenue of $28.24 billion, beating the $26.42 billion consensus estimate and marking a 25.5% increase, but earnings per share landed at $0.33, missing the $0.50 forecast. Return on equity registered at 3.82%, net profit margin at 3.67%, and the trailing price